In relation to the other two HCC cellular lines, it has been described that the effects of sorafenib, which belongs to the tyrosine kinase inhibitors family, depends on several factors such as cell differentiation, mitochondrial respiration, and p53 status [34]. The gene discussed is TP53; the disease is hepatocellular carcinoma.